NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 126 filers reported holding NUVATION BIO INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,457 | -25.6% | 100,341 | -0.0% | 0.00% | – |
| Q2 2023 | $180,679 | +31.0% | 100,377 | +20.8% | 0.00% | – |
| Q1 2023 | $137,929 | -13.0% | 83,090 | 0.0% | 0.00% | – |
| Q4 2022 | $158,582 | -7.0% | 83,090 | +8.0% | 0.00% | – |
| Q3 2022 | $170,482 | +16.0% | 76,957 | +69.7% | 0.00% | – |
| Q2 2022 | $146,918 | -54.4% | 45,345 | -25.9% | 0.00% | – |
| Q1 2022 | $321,865 | -48.8% | 61,191 | -17.3% | 0.00% | – |
| Q4 2021 | $629,000 | +81.8% | 73,969 | +112.6% | 0.00% | – |
| Q3 2021 | $346,000 | +87.0% | 34,791 | +74.9% | 0.00% | – |
| Q2 2021 | $185,000 | – | 19,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |